While the precise role of neurogenesis in AD pathogenesis remains under investigation, several preclinical studies suggest that boosting neurogenesis may ameliorate cognitive decline and neuronal loss, especially when combined with interventions targeting Aβ and tau pathology [9,13]. This evidence concerns the gene MAPT and Alzheimer disease.